Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voclosporin intensification versus standard dual therapy in proliferative lupus nephritis with serial kidney and blood immune profiling
NL-OMON60331Phase 4Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of voclosporin in lupus nephritis (LN), systemic lupus erythematosus (SLE), sponsored by Amsterdam University Medical Center. Started Apr 2026; status: recruiting.
02
Drugs
voclosporin
03
Conditions
lupus nephritis (LN)systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NL-OMON60331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60331.